Warning: The NCBI web site requires JavaScript to function. more...
Polymorphism of PfATPase in Niger: detection of three new point mutations.
Ibrahim ML, Khim N, Adam HH, Ariey F, Duchemin JB.
Malar J. 2009 Feb 18;8:28.
Related citations
Field-based evidence of fast and global increase of Plasmodium falciparum drug-resistance by DNA-microarrays and PCR/RFLP in Niger.
Ibrahim ML, Steenkeste N, Khim N, Adam HH, Konaté L, Coppée JY, Ariey F, Duchemin JB.
Malar J. 2009 Feb 23;8:32.
No PfATPase6 S769N mutation found in Plasmodium falciparum isolates from China.
Zhang G, Guan Y, Zheng B, Wu S, Tang L.
Malar J. 2008 Jul 8;7:122.
Plasmodium falciparum isolates from southern Ghana exhibit polymorphisms in the SERCA-type PfATPase6 though sensitive to artesunate in vitro.
Kwansa-Bentum B, Ayi I, Suzuki T, Otchere J, Kumagai T, Anyan WK, Osei JH, Asahi H, Ofori MF, Akao N, Wilson MD, Boakye DA, Ohta N.
Malar J. 2011 Jul 11;10:187.
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK.
Malar J. 2009 Feb 26;8:34.
Therapeutic efficacy of artemether-lumefantrine in uncomplicated falciparum malaria in India.
Valecha N, Srivastava P, Mohanty SS, Mittra P, Sharma SK, Tyagi PK, Pradhan K, Dev V, Singh R, Dash AP, Sharma YD.
Malar J. 2009 May 19;8:107.
Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia.
Mkulama MA, Chishimba S, Sikalima J, Rouse P, Thuma PE, Mharakurwa S.
Malar J. 2008 May 21;7:87.
[Plasmodium falciparum chloroquine and pyrimethamine resistance monitoring network with molecular tools in the Niger River valley, Republic of Niger].
Ibrahim ML, Hassane H, Konate L, Adamou S, Ousmane I, Adehossi E, Jeanne I, Duchemin JB.
Bull Soc Pathol Exot. 2008 Feb;101(1):47-9. French.
Confirmation of emergence of mutations associated with atovaquone-proguanil resistance in unexposed Plasmodium falciparum isolates from Africa.
Happi CT, Gbotosho GO, Folarin OA, Milner D, Sarr O, Sowunmi A, Kyle DE, Milhous WK, Wirth DF, Oduola AM.
Malar J. 2006 Oct 4;5:82.
Analysis of genetic mutations associated with anti-malarial drug resistance in Plasmodium falciparum from the Democratic Republic of East Timor.
de Almeida A, Arez AP, Cravo PV, do Rosário VE.
Malar J. 2009 Apr 9;8:59.
Different mutation patterns of atovaquone resistance to Plasmodium falciparum in vitro and in vivo: rapid detection of codon 268 polymorphisms in the cytochrome b as potential in vivo resistance marker.
Schwöbel B, Alifrangis M, Salanti A, Jelinek T.
Malar J. 2003 Mar 19;2:5. Epub 2003 Mar 19.
Rapid increase of Plasmodium falciparum dhfr/dhps resistant haplotypes, after the adoption of sulphadoxine-pyrimethamine as first line treatment in 2002, in southern Mozambique.
Enosse S, Magnussen P, Abacassamo F, Gómez-Olivé X, Rønn AM, Thompson R, Alifrangis M.
Malar J. 2008 Jul 1;7:115.
In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from São Tomé and Príncipe.
Ferreira ID, Lopes D, Martinelli A, Ferreira C, do Rosário VE, Cravo P.
Trop Med Int Health. 2007 Mar;12(3):353-62.
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
Lim P, Alker AP, Khim N, Shah NK, Incardona S, Doung S, Yi P, Bouth DM, Bouchier C, Puijalon OM, Meshnick SR, Wongsrichanalai C, Fandeur T, Le Bras J, Ringwald P, Ariey F.
Malar J. 2009 Jan 12;8:11.
Nonradioactive heteroduplex tracking assay for the detection of minority-variant chloroquine-resistant Plasmodium falciparum in Madagascar.
Juliano JJ, Randrianarivelojosia M, Ramarosandratana B, Ariey F, Mwapasa V, Meshnick SR.
Malar J. 2009 Mar 16;8:47.
Plasmodium falciparum from Pará state (Brazil) shows satisfactory in vitro response to artemisinin derivatives and absence of the S769N mutation in the SERCA-type PfATPase6.
Ferreira ID, Martinelli A, Rodrigues LA, do Carmo EL, do Rosário VE, Póvoa MM, Cravo P.
Trop Med Int Health. 2008 Feb;13(2):199-207.
In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R, Tan-Ariya P, Mungthin M.
Malar J. 2008 Jan 28;7:23.
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
Sutherland CJ, Laundy M, Price N, Burke M, Fivelman QL, Pasvol G, Klein JL, Chiodini PL.
Malar J. 2008 Nov 20;7:240.
Low efficacy of chloroquine: time to switchover to artemisinin-based combination therapy for falciparum malaria in India.
Valecha N, Joshi H, Mallick PK, Sharma SK, Kumar A, Tyagi PK, Shahi B, Das MK, Nagpal BN, Dash AP.
Acta Trop. 2009 Jul;111(1):21-8. Epub 2009 Feb 7.
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K, Maiga H, Newman RD, McMorrow ML, Hoppe A, Yattara O, Traore H, Kone Y, Guirou EA, Saye R, Traore B, Djimde A, Doumbo OK.
Malar J. 2009 Jan 7;8:5.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on